The 2021 Congress Learning Objectives are as follows:
After this educational event, attendees should be able to:
- Recall and contrast the latest advances in genitourinary cancer diagnosis, staging, and management
- Discuss advanced cancer treatments, including immunotherapy for genitourinary cancers
- Discuss the latest advances in robotic platforms and minimally invasive surgical techniques in urology
- Describe the causes and treatment of lower urinary tract dysfunction, including the newest therapies for prostate enlargement
- Summarize the pathophysiology and management of genitourinary fistulae and stricture disease
- Describe emerging urological infections and the impact of COVID-19 on urological care
- Detail surgical approaches to urinary stone disease
- List common genital emergencies and their management
- Characterize the assessment and management of male infertility
- Define treatment options for erectile dysfunction and learn new skills in the principles of penile prosthesis placement
- Recall urologic issues specific to the geriatric population
- List hormonal treatments for urologic patients
- Present diagnostic and management approaches to common pediatric urological diseases
SIU 2021 Scientific Programme
Last updated: June 18, 2021
Please Note: All session times are listed in Gulf Standard Time (GST).
To view the PDF version, please click here.
Wednesday, November 10
Please click on the session titles to view the session details when available.
|
0800-1200
|
|
SYMP-01: 9th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)
Co-Chairs: Mohammed Lezrek, Morocco / Arvind Ganpule, India
Honorary Chair: Daniel Yachia, Israel
|
|
0800-1000
|
|
SYMP-02: Pan-African Urological Surgeons Association (PAUSA) Symposium
Chair: Mohamed Jalloh, Senegal
|
|
0800-1000
|
|
SYMP-03: International Society of Reconstructive Urology (ISORU) Symposium
Co-Chair: Sanjay Kulkarni, India
|
|
0900-1200
|
|
SYMP-04: Indian Urology Around the World
Chair: Chiruvella Mallikarjuna, India
|
|
1000-1200
|
|
SYMP-05: Society of Genitourinary Reconstructive Surgeons (GURS) Symposium
Co-Chairs: Miroslav Djordjevic, Serbia / Francisco E. Martins, Portugal / Benjamin N. Breyer, United States
|
|
1300-1500
|
|
SYMP-06: Urological Association of Asia (UAA) Symposium
Co-Chairs: Allen W. Chiu, Taiwan / Myung-Soo Choo, South Korea
|
|
1300-1700
|
|
SYMP-07: Joint SIU-Chinese Urological Association (CUA)
Co-Chairs: Badrinath Konety, United States / Li-Ping Xie, People's Republic of China
|
|
1300-1510
|
|
SYMP-08: Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA) Symposium
Co-Chairs: Patrick Mburugu, Kenya / Shingai Mutambirwa, South Africa / Saeed R. Samnakay, Kenya
|
|
1300-1500
|
|
SYMP-09: International Consultation on Urological Diseases (ICUD) and World Urologic Oncology Federation (WUOF) Consultation: Molecular Biomarkers in Urology
Chair: Laurence Klotz, Canada
|
|
1500-1700
|
|
SYMP-10: Joint SIU-Korean Urological Association (KUA) Symposium
Co-Chairs: Stavros Gravas, Greece / Sung Kyu Hong, South Korea
|
|
1500-1700
|
|
SYMP-11: Symposium on Focal Therapy
Co-Chairs: Jean de la Rosette, Turkey / Jurgen Futterer, The Netherlands / Rafael Sanchez-Salas, France
|
|
Following this session, attendees will be able to foster a FT session in both renal and prostate cancer to further improve the understanding of an organ sparing approach.
|
Thursday, November 11
Please click on the session titles to view the session details when available.
|
0730-1500
|
|
LS: Semi-Live Surgery
Co-Chairs: Jean de la Rosette, Turkey / Thomas Herrmann, Germany / Rafael Sanchez-Salas, France
|
|
0800-1500
|
|
TIPS-01: SIU Tips and Tricks Session
Co-Chairs: Peter Black, Canada / Sean P. Elliott, United States / Stavros Gravas, Greece
|
|
0800-1000
|
|
SIU Academy
|
|
1300-1500
|
|
SIU Journal
|
|
|
0800-1700
|
|
SYMP-12: World Urological Oncology Federation (WUOF) Symposium
Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada
|
|
1000-1200
|
|
SYMP-13: Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
Co-Chairs: Alejandro Rodriguez, United States / Rafael Sanchez-Salas, France
|
|
1000-1200
|
|
SYMP-14: Arab Urology Around the World (AAU) Symposium
Chair: Raed Azhar, Saudi Arabia
|
|
1300-1500
|
|
SYMP-15: Iranian Urological Association (IUA) Symposium
Chair: Abbas Basiri, Iran
|
|
1300-1500
|
|
SYMP-16: National Society Delegates
Chair: Sanjay Kulkarni, India
|
|
1300-1500
|
|
SYMP-17: International Neuro-Urology Society (INUS) Symposium
Chair: Helmut Madersbacher, Switzerland
|
|
1500-1700
|
|
SYMP-18: Hellenic Urological Association (HUA) Symposium
Co-Chairs: Ioannis Gkialas, Greece / Mohamad Moussa, Lebanon
|
|
1500-1700
|
|
SYMP-19: Eurasian (EUA, Turkish Urology Team) Symposium
Chair: Selami Albayrak, Turkey
|
Friday, November 12
Please click on the session titles to view the session details when available.
|
0730-0900
|
|
IC-01: Instructional Course 01 - PCNL Tips/Tricks and Pitfalls
Chair: Athanasios Papatsoris, Greece
|
|
0730-0745
|
|
How to Optimize the Patient Pre-Op
Athanasios Papatsoris, Greece
|
|
|
|
Q&A
Athanasios Papatsoris, Greece
|
|
0750-0805
|
|
How to Simply Perform Miniaturized PCNL
Janak Desai, India
|
|
0805-0810
|
|
Q&A
Janak Desai, India
|
|
0810-0825
|
|
How to Efficiently and Safely Perform Standard PCNL
|
|
0825-0830
|
|
Q&A
|
|
0830-0850
|
|
The Do's and the Don'ts in Nightmare Cases: Vote for the Best Option!
Mohamad Moussa, Lebanon
|
|
0850-0900
|
|
Discussion & Voting
Janak Desai, India
Mohamad Moussa, Lebanon
Athanasios Papatsoris, Greece
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Prepare a patient for a successful PCNL (e.g., optimize patients with UTI or severe obesity, choose proper imaging and positioning as well as select the best calyx to enter the PC)
- Perform mini PCNL in a simple standardized step by step way
- Achieve a stone-free rate during a standard PCNL
- Prevent nightmare complications and how to manage them
|
|
|
0755-0900
|
|
MC-02: Master Class 02 - Advanced Kidney Cancer
Co-Chairs: Axel Bex, United Kingdom / Peter Mulders, The Netherlands
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Recall the latest developments in systemic therapy in mRCC
- Compare neo- and adjuvant therapy indications in advanced RCC
- Explain the role of nephrectomy in the systemic setting of RCC
- Apply case-based knowledge in advanced RCC
|
|
0800-0900
|
|
MC-01: Master Class 01 - Refractory Overactive Bladder Syndrome
Co-Chairs: Sanjay Sinha, India / Alan Wein, United States
|
|
0900-1045
|
|
PL-01: Plenary 01
|
|
0940-0955
|
|
Emirates Urological Society (EUS) Lecture: Oxidative Stress and Male Infertility
Hussein Kandil, United Arab Emirates
Learning Objectives:
At the end of Dr. Kandil's lecture, attendees will be able to:
- Explain that nearly 30-80% of infertile males produce high levels of reactive oxygen species (ROS), hence, oxidative stress evaluation remains crucial in the management of male infertility
- Understand the link between oxidative stress and male fertility potential
- Highlight on the term Male Oxidative Stress Infertility (MOSI)
- Understand the way oxidative stress is measured using the most up-to-date available tools with emphasis on the MiOXSYS method of measuring oxidation-reduction potential (ORP)
|
|
0955-1010
|
|
Pan African Urological Association (PAUSA) Lecture: Challenges and opportunities in Urethral Reconstruction in Sub Saharan Africa
Mohamed Jalloh, Senegal
|
|
1010-1025
|
|
State-of-the-Art Lecture: Genetics of Bladder Cancer
Seth Lerner, United States
Learning Objectives:
At the end of Dr. Lerner's lecture, attendees will be able to:
- Apply genomic alterations to risk stratification of non-muscle invasive bladder cancer
- Interpret the key findings of the TCGA project in muscle invasive bladder cancer (MIBC)
- Describe translational opportunities and examples from multiomic profiling of MIBC
- Understand genomic predictors of response to chemotherapy and immunotherapy
|
|
1025-1040
|
|
State-of-the-Art Lecture: Novel Therapies in RCC and the Impact on Surgery
Peter Mulders, The Netherlands
|
|
|
1045-1115
|
|
Break
|
|
1045-1245
|
|
TIPS-02: SIU Tips and Tricks Session
Chair: Laurence Klotz, Canada
|
|
|
|
1115-1245
|
|
HT-01: Hot Topics 01 - Harnessing Artificial Intelligence (AI) in Urology
Co-Chairs: Jean-Christophe Bernhard, France / Quoc-Dien Trinh, United States
|
|
1115-1245
|
|
HT-02: Hot Topics 02 - PSMA Theranostics
Co-Chairs: Jeremie Calais, United States / Tobias Maurer, Germany
|
|
1115-1117
|
|
Introduction
Jeremie Calais, United States
Tobias Maurer, Germany
|
|
1117-1136
|
|
Initial Staging with PSMA
Robert Reiter, United States
|
|
1136-1155
|
|
Role of Targeted Salvage Surgery in Biochemical Recurrence (BCR)
Tobias Maurer, Germany
|
|
1155-1214
|
|
Role of Targeted Salvage Radiation and Metastasis-directed Therapy in Biochemical Recurrence (BCR)
Uğur Selek, Turkey
|
|
1214-1233
|
|
Role of PSMA PET in mCRPC and PSMA-RLT
|
|
1233-1243
|
|
Q&A and Discussion
|
|
1243-1245
|
|
Take-home Messages
Jeremie Calais, United States
Tobias Maurer, Germany
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand the benefit and limitations of staging with PSMA PET in newly diagnosed prostate cancer
- Estimate the role of PSMA-guided salvage surgery and to identify suitable patients
- Understand the indication and outcomes of targeted radiotherapy in oligometastatic prostate cancer
- Estimate the value of PSMA PET in the mCRPC setting and the role of PSMA-radioligand therapy
|
|
|
1115-1245
|
|
IC-03: Instructional Course 03 - Imaging-Guided Biopsy Diagnostic Pathway in Prostate Cancer
Co-Chairs: Peter Black, Canada / Marc Dall'Era, United States
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand risk stratification of prostate lesions on MRI using Prostate Imaging Reporting & Data System (PI-RADS)
- Review the clinical trial data evaluating the role of prostate MRI prior to prostate biopsy
- Learn the steps to establish an image-guided biopsy programme
- Understand how novel imaging such as high-resolution US may be incorporate into the prostate cancer screening pathway
- Understand the limitations of MRI for prostate cancer detection and ‘best practices’ on when and how to perform prostate biopsy in the setting of a negative MRI
|
|
1115-1245
|
|
IC-04: Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Chair: Dean Elterman, Canada
|
|
1115-1120
|
|
Introduction to Novel BPH Therapies
Dean Elterman, Canada
|
|
1120-1132
|
|
Laser Transurethral Endoscopic Enucleation of the Prostate (EEP)
Vincent Misrai, France
|
|
1132-1136
|
|
Q&A
Vincent Misrai, France
|
|
1436-1448
|
|
UroLift
|
|
1448-1452
|
|
Q&A
|
|
1452-1504
|
|
Rezum
|
|
1504-1508
|
|
Q&A
|
|
1508-1520
|
|
Aquablation
Enrique Rijo, Spain
|
|
1520-1524
|
|
Q&A
Enrique Rijo, Spain
|
|
1524-1536
|
|
Stents
Dean Elterman, Canada
|
|
1536-1540
|
|
Q&A
Dean Elterman, Canada
|
|
1540-1545
|
|
Closing Remarks
Dean Elterman, Canada
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the mechanism of action and technique for each of the novel BPH therapies
- Select the best patients for each procedure type based upon patient and prostate characteristics
- Gain knowledge of the clinical data supporting the use of each modality
- Understand best-practice technique for each modality based upon the literature and expert opinion
- Gain an appreciation for the challenges encountered and troubleshooting for each technology
- Appreciate the “tips & tricks” provided by the experts for performing these novel BPH therapies
|
|
|
1115-1245
|
|
JS-01: Joint SIU-Endourology Session
Chair: Mahesh R. Desai, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand technical details of some challenging aspects of complex surgeries
- Understand the newer developments in areas of focal therapy for renal tumors and ureteral stents
- Learn all controversies about SWL, holmium laser and newer modalities of BPH treatment
- Gain knowledge of future developments and technical details of various endourological procedures
|
|
1115-1245
|
|
JS-02: Joint SIU-International Society of Reconstructive Urology (ISORU) Session
Co-Chairs: Reynaldo Gómez, Chile / Sanjay Kulkarni, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Distinguish the different types of hypospadias repair and develop a simplified management plan
- Distinguish the difference in management options of radiation induced strictures
- Recognize the latest concepts in transgender surgery
- Determine the technique to preserve bulbar arteries in anastomotic urethroplasty
- Evaluate complex stricture and plan the appropriate management
|
|
1245-1415
|
|
Lunch Break
|
|
1400-1700
|
|
SYMP-20: Emirates Urological Society (EUS) Symposium
Chair: Yasser Farahat, United Arab Emirates
|
|
1415-1545
|
|
IC-05: Instructional Course 05 - Urological Care for Transgender Patients
Chair: Dmitriy Nikolavsky, United States
|
|
Learning Objectives;
At the end of this session, attendees will be able to:
- Gain an improved understanding of transition, gaining familiarity with altered genitourinary anatomy in transgender patients
- Understand the risks of malignancies and thromboembolic events after hormonal therapy
- Understand the short- and long-term risks of gender affirmation surgery
- Recognize and evaluate most common GU complications of gender affirmation surgery
- Familiarize with changes in anatomy in transgender patients to provide long-term urological care
|
|
1415-1545
|
|
IC-06: Instructional Course 06 - Minimally-Invasive PCNL (Mini-PCNL): The Way Forward
Chair: Madhu S Agrawal, India
|
|
1415-1435
|
|
Percutaneous Access with Ultrasonograpy and Fluoroscopy Guidance
Madhu S Agrawal, India
|
|
1435-1450
|
|
Positioning - Prone or Supine, Single Step Tract Dilation
Sven Lahme, Germany
|
|
1450-1500
|
|
Use of Various Energy Sources for Stone Fragmentation
Dilip Kumar Mishra, India
|
|
1500-1515
|
|
Novel Concept-Suction in mini-PCNL - ‘Super mini-perc’
Giorgio Mazzon, Italy
|
|
1515-1525
|
|
Flexible mini-PCNL and Various Exit Strategies
Madhu S Agrawal, India
|
|
1525-1545
|
|
Case-Based Discussion and Q&A
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Guide participant about how to perform successful puncture in PCNL by own self, using ultrasound and fluoroscopy for access, singly or in combination (rather than being dependent on the radiologist for obtaining access)
- Understand the steps of mini-PCNL procedure, including single-step tract dilatation, use of mini-nephroscope, and the principle of ‘vacuum-cleaner effect for retrieval of fragments
- Employ different energy sources for stone fragmentation including high-power laser, and use of different exit strategies, as explained during the course
- Apply knowledge of minimally-invasive PCNL in their own practice to improve the patient outcomes in terms of reduced morbidity
|
|
|
1415-1545
|
|
IC-07: Instructional Course 07 - Focal Therapy for Locoregional or Oligometastatic Recurrence of Prostate Cancer
Chair: Rafael Sanchez-Salas, France
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Define oligometastatic disease and recurrence in Prostate Cancer
- Understand how to select patients for eventual ablative treatment: Biomarkers and Imaging
- Understand the role of Systemic therapies
- Understand the role Radiotherapy
- Understand the role of surgical treatment
- Understand the role of Focal Therapy
|
|
1415-1545
|
|
MV-01: Master Videos 01 - Genitourinary Fistulae
Co-Chairs: Ganesh Gopalakrishnan, India / Sherif Mourad, Egypt
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the concept and physiopathology of “different types of fistulae”
- Identify and select the proper management and approach of fistula repair
- Diagnose and indicate the adequate management of complicated vesicovaginal fistula
|
|
1415-1715
|
|
INN: SIU Innovators' Symposium
Co-Chairs: Renu Eapen, Australia / Maria Carmen Mir, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Improve telemedicine skills during encounters to optimize outcomes.
- Gain a broader knowledge on available EMR platforms (pros and cons)
- Understand reimbursement issue related to telemedicine
- Recognize health policy and regulations within different countriesImprove knowledge on current mentoring options and facilitation of networking for surgical/medical skills improvement
- Define state of the art status on gender disparities across geographic areas
- Facilitate establishment of mentorship programmes within urology societies
- Dissect regulatory rules to facilitate in establishment of new drug treatments
|
|
1545-1615
|
|
Break
|
|
1615-1745
|
|
IC-08: Instructional Course 08 - Case Based Discussions in Neuro-urology
Chair: Rizwan Hamid, United Kingdom
Faculty: David Castro-Díaz, Spain / Sherif Mourad, Egypt
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Understand the management principles in Neurourology
- Appreciate the differences in managing various neuro-urological conditions
- Gain confidence in tacking neurourological problems
- Understand the recommendations in International neuro-urological guidelines
- Formulate a management plan for a neuro-urological patient
|
|
1615-1745
|
|
IC-09: Instructional Course 09 - Complex Penile and Urethral Reconstruction in Adults with Prior Hypospadias or Epispadias
Chair: Miroslav Djordjevic, Serbia
|
|
1615-1620
|
|
Introduction
Miroslav Djordjevic, Serbia
|
|
1620-1635
|
|
Hypospadias in Adults - Primary Repair
Marta Bizic, Serbia
|
|
1635-1650
|
|
Late Complication of Hypospadias
Alaa El Ghoneimi, France
|
|
1650-1705
|
|
Re-Doing Epispadias After Failed Surgery in Childhood
Miroslav Djordjevic, Serbia
|
|
1705-1720
|
|
Penile Curvature in Adults: Peyronie’s Disease or Congenital?
Cooper Benson, United States
|
|
1720-1740
|
|
Q&A and Discussion
|
|
1740-1745
|
|
Conclusions
Miroslav Djordjevic, Serbia
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
-
Define modalities of hypospadias surgery in adult patients
-
Recognize complications of hypospadias treatment and different surgical approaches for their resolution
-
Recognize most important surgical steps in re-do epispadias repair; define and achieve successful outcome
-
Recognize penile curvature in adults as a consequence of Peyronie's disease or congenital deformity
-
Conduct good postoperative care and treatment.
|
|
|
1615-1745
|
|
IC-10: Instructional Course 10 - Evolving Treatment Landscape of Cancer: Immunotherapy in Urological Cancer
Chair: Kevin Lu, Taiwan
Faculty: Ahmed Özet, Turkey
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand basics of immunology in cancer immunotherapy and current potential predictive and/or prognostic biomarkers in application of immune checkpoint inhibitors in urological cancer
- Discuss and evaluate the current available clinical evidence for immunotherapy in urothelial cancer, in neoadjuvant, adjuvant and metastatic setting
- Appraise current treatment strategies for metastatic renal cell cancer, IO + IO or IO+TKI in first line setting, and subsequent therapies after failure of 1st-line therapies
- Re-appraise Current status and barriers of immunotherapy in PCa
- Apply shared decision-making model of Ca immunotherapy in clinical practice
|
|
1615-1745
|
|
MV-02: Master Videos 02 - Endoscopic Surgery for BPH: Compare and Contrast
Co-Chairs: Athanasios Papatsoris, Greece / Anil Kumar Varshney, India
|
|
1615-1630
|
|
Aquablation
Vincent Misrai, France
|
|
1630-1645
|
|
Urolift: Minimally Invasive Surgical Procedures for LUTS due to BPO: Focus on PUL
Mauro Gacci, Italy
|
|
1645-1700
|
|
Various Endoscopic Enucleation Procedures in Europe
Javier Sanchez Macias, Spain
|
|
1700-1715
|
|
Enucleation by Holmium Laser (HoLEP)
Anil Kumar Varshney, India
|
|
1715-1730
|
|
BipolEP
Athanasios Papatsoris, Greece
Dimitrios Staios, Greece
|
|
1730-1740
|
|
Q&A + Panel Discussion
Mauro Gacci, Italy
Javier Sanchez Macias, Spain
Vincent Misrai, France
Athanasios Papatsoris, Greece
Dimitrios Staios, Greece
Anil Kumar Varshney, India
|
|
1740-1745
|
|
Take‐home Message
Athanasios Papatsoris, Greece
Anil Kumar Varshney, India
|
|
Learning Objectives:
At the conclusion of this course, attendees will be able to:
- Discuss the place of endoscopic surgeries in the overall management of BPH
- Compare various indications, contraindications, technical details and know how to do these procedures
- Learn where they can go wrong and how to minimize complications
- Gain tips to provide better outcomes
- Understand the limitations and scenarios when not to do these operations
- Highlight efficacy parameters, safety concerns, durability, versatility, cost-effectiveness, learning and mentoring
|
|
|
1615-1750
|
|
IS-01: Interactive Session 01 - Open Surgery in 2021: When and Why?
Co-Chairs: Hassan Abol-Enein, Egypt / Amlesh Seth, India
|
|
1615-1620
|
|
Introduction
Hassan Abol-Enein, Egypt
Amlesh Seth, India
|
|
1620-1635
|
|
Open Surgery in Bladder Cancer
Hassan Abol-Enein, Egypt
|
|
1635-1642
|
|
Case Discussion 1 (with Audience Participation) Bladder Cancer
Hassan Abol-Enein, Egypt
|
|
1642-1657
|
|
Open retroperitoneal lymph node dissection (RPLND)
Joel Sheinfeld, United States
|
|
1657-1704
|
|
Case Discussion 2 (with Audience Participation) Testicular Cancer
|
|
1704-1719
|
|
Open Surgery in renal cell carcinoma (RCC)
Amlesh Seth, India
|
|
1719-1726
|
|
Case Discussion 3 (with Audience Participation) Kidney Cancer
Amlesh Seth, India
|
|
1726-1741
|
|
Trans-perineal Radical Prostatectomy
Selami Albayrak, Turkey
|
|
1741-1748
|
|
Case Discussion 4 (with Audience Participation) Prostate Cancer
Selami Albayrak, Turkey
|
|
1748-1750
|
|
Closing Remarks
Hassan Abol-Enein, Egypt
Amlesh Seth, India
|
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Gain knowledge of open surgery in bladder cancer and renal cell carcinoma (RCC)
- Understand how open retroperitoneal lymph node dissection (RPLND) is conducted in testicular cancer
- Understand the applications of Trans-perineal Radical Prostatectomy in prostate cancer
|
Saturday, November 13
Please click on the session titles to view the session details when available.
|
0700-0800
|
|
GA: General Assembly
|
|
0730-0900
|
|
IC-11: Instructional Course 11 - Bleeding Complications of PCNL - Prevention & Management
Chair: Ravindra Sabnis, India
|
|
0730-0735
|
|
Introduction
Ravindra Sabnis, India
|
|
0735-0750
|
|
Etiological Factors Leading to Bleeding Complication – Pre, Intra & Post-op
Ravindra Sabnis, India
|
|
0750-0805
|
|
Intra-op Excessive Bleeding – How to Tackle
Michael Borofsky, United States
|
|
0805-0820
|
|
Post-op Bleeding – Step-by-Step Management
Brian Matlaga, United States
|
|
0820-0835
|
|
Preventing Steps to Reduce Bleeding Complications in PCNL
Jean de la Rosette, Turkey
|
|
0835-0900
|
|
Case-Based Discussion
Moderator: Ravindra Sabnis, India
Panelists
Michael Borofsky, United States
Jean de la Rosette, Turkey
Brian Matlaga, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the cause of bleeding
- Explain when, why and at which steps, bleeding occurs while doing PCNL
- Identify the cause of post PCNL bleeding
- Understand how to manage bleeding once it occurs
- Determine the steps to be taken to prevent bleeding
|
|
|
0730-0900
|
|
IC-12: Instructional Course 12 - Tools to Make Caring for Pelvic Pain Easier and More Successful for the Urologist
Chair: Elise De, United States
Faculty: Charles E. Argoff, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Explain differential diagnosis for causes of pelvic pain
- Determine what to try first, what not to miss, and what to do next
- Evaluate associated conditions – signs of systemic etiology and how to approach
|
|
0730-0900
|
|
IC-13: Instructional Course 13 - PDE 5 Inhibitor Non-Responders for Erectile Dysfunction
Chair: Vipan Bhatia, United Arab Emirates
Faculty: Salam Alhasani, United Arab Emirates / Mamoun Hamid Elmamoun, United Kingdom
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Define PDE 5 inhibitor non responders and incidence and avoid over-diagnosis
- Identify causes, need for proper history taking, Investigations, testosterone deficiency, couple therapy
- Explain combination medical therapy with multiple PDE 5 inhibitors and testosterone supplementation
- State the role of minimally invasive therapy including penile shock wave therapy and platelet rich therapy
- Discuss future therapies on the horizon - gene and stem cell therapy
- Recognize practical guidelines
|
|
0800-0900
|
|
MC-03: Master Class 03 - Geriatric Urology
Co-Chairs: Narmada Gupta, India / Thomas Guzzo, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Evaluate patients for pre-operative frailty, with an understanding of risk stratification and its implications
- Understand urogenital problems after menopause, i.e., the effects of oestrogen replacement
- Gain knowledge of Detrusor underactivity in aging patients (evaluation and management)
- Apply knowledge of bladder outlet obstruction in frail elderly patients, with expert tips on approach to management
|
|
0800-0900
|
|
MC-04: Master Class 04 - Genital Emergencies
Co-Chairs: Tom Lue, United States / Rupin Shah, India
|
|
0800-0802
|
|
Introduction
Tom Lue, United States
Rupin Shah, India
|
|
0802-0810
|
|
Pathophysiology and Clinical Diagnostic Approach
Asif Muneer, United Kingdom
|
|
0810-0820
|
|
Medical Management of Ischemic Priapism
Rupin Shah, India
|
|
0820-0830
|
|
Novel Strategies for The Management of Ischemic Priapism
Faysal Yafi, United States
|
|
0830-0835
|
|
Penile Implant for Ischemic Priapism
Asif Muneer, United Kingdom
|
|
0835-0850
|
|
Challenging Case Scenarios
Tom Lue, United States
|
|
0850-0900
|
|
Q&A
Tom Lue, United States
Asif Muneer, United Kingdom
Rupin Shah, India
Faysal Yafi, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Differentiate between different types of priapism
- Plan appropriate therapy as per specific ethology
- Implement medical and surgical treatment options
- Manage a priapism emergency competently and confidently
|
|
|
0800-1600
|
|
NURS: 6th SIU Global Nurses' Educational Symposium
Co-Chairs: Hussam Al Nusair, United Arab Emirates / Amparo Gudrun Camacho, United States
|
|
0800-0805
|
|
Welcome
Hussam Al Nusair, United Arab Emirates
Amparo Gudrun Camacho, United States
|
|
0805-0830
|
|
Diagnosis and Treatment of Bladder Cancer
Waleed Hassen, United Arab Emirates
|
|
0830-0850
|
|
Ostomy Management
Vashti Livingston, United States
|
|
0850-0910
|
|
ERAS: Enhanced Recovery After Surgery
Amparo Gudrun Camacho, United States
|
|
0910-0935
|
|
Compliance with Erectile Dysfunction Treatment in Men with Prostate Cancer
Christian Nelson, United States
|
|
0935-1000
|
|
Case Study and Clinicians’ Experiences: Nursing Support for Patients with Sexual Dysfunction
Samantha Strumeier, United States
|
|
1000-1015
|
|
Infection Control for Penile Implantation
Monica Chan, United Arab Emirates
|
|
1015-1030
|
|
Break and ePoster Poster Viewing
|
|
1030-1055
|
|
BPH/LUTS Treatment
Jaspreet S. Sandhu, United States
|
|
1055-1105
|
|
Nursing Considerations for Patients with Urinary Symptoms
Lydia Nahorniak, United States
|
|
1105-1115
|
|
Nursing Practice Related to Intermittent Catheterization Evidence-Based Practice
Marcerey Sison Quejada, United Arab Emirates
|
|
1115-1120
|
|
Q&A
|
|
1120-1200
|
|
Abstract Presentations
Moderator: Amparo Gudrun Camacho, United States
|
|
1200-1250
|
|
Break and ePoster Viewing
|
|
1250-1315
|
|
The Role of Imaging and Novel Biomarkers to Guide Active Surveillance
Behfar Ehdaie, United States
|
|
1315-1340
|
|
Considerations When Performing Prostate Biopsies
Kenny Lin, United States
|
|
1340-1350
|
|
Urodynamic Setup
Abigail Rome, United Arab Emirates
|
|
1350-1400
|
|
Interpretation and Artifacts
Dean Elterman, Canada
|
|
1400-1410
|
|
Neuromodulation
Dean Elterman, Canada
|
|
1410-1415
|
|
Q&A
|
|
1415-1440
|
|
Therapeutic Modalities and Management of Complex Stone Disease
Daniel Pérez-Fentes, Spain
|
|
1440-1455
|
|
Operating Room Settings for Stone Surgery (PCNL, Ureteroscopy with Lithotripsy)
Rogelio Silverio, United Arab Emirates
|
|
1455-1510
|
|
Laser Safety in Surgery – General Safety and Specific Requirements in OT
Rogelio Silverio, United Arab Emirates
|
|
1510-1535
|
|
Urosepsis
Sondos Jarrad, United Arab Emirates
|
|
1535-1545
|
|
Use of Chlorhexidine 0.1% for Urethral Cleaning in Pre- and Post- Foley’s Catheter Insertion (Evidence-Based Practice)
Marcerey Sison Quejada, United Arab Emirates
|
|
1545-1555
|
|
Structuring Skin Care to Prevent Incontinence Associated Dermatitis
Marilou Manarang, United Arab Emirates
|
|
1555-1605
|
|
Comparative Study of Incontinence Associated Dermatitis Treatments- (Evidence-based practice)
Marilou Manarang, United Arab Emirates
|
|
1605-1610
|
|
Q&A
|
|
1610-1615
|
|
Meeting Close and Invitation to 7th SIU Global Nurses' Educational Symposium
Hussam Al Nusair, United Arab Emirates
Amparo Gudrun Camacho, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Review diagnosis and surgical treatment for bladder cancer
- Discuss ostomy care interventions
- Discuss ERAS protocol basics
- Establish erectile dysfunction treatment compliance in men with prostate cancer and how this affects their recovery
- Determine infection control interventions for penile prosthesis
- Describe the causes and treatment of lower urinary tract dysfunction, including the newest therapies for prostate enlargement
- Consider voiding dysfunction interventions and the use of intermittent catheterization
- Evaluate the role of imaging and novel biomarkers in the treatment of patients with prostate cancer on active surveillance
- Describe nursing considerations when conducting prostate biopsies
- Detail urodynamic testing setup and its interpretation
- Review neuromodulation as treatment modality in voiding dysfunction
- Detail surgical approaches to urinary stone disease
- Describe operating room settings for stone surgery and laser safety
- Define treatment of urosepsis and the use of skin cleansers during Foley catheter insertions
- Discuss skincare considerations for patients with wounds and dermatitis
|
|
|
0900-1045
|
|
PL-02: Plenary 02
|
|
|
|
1045-1115
|
|
Break
|
|
1115-1245
|
|
HT-03: Hot Topics 03 - Future of Urology - Next 20 Years
Co-Chairs: Sung Kyu Hong, South Korea / Bhaskar K. Somani, United Kingdom
|
|
1115-1118
|
|
Introduction
Bhaskar K. Somani, United Kingdom
|
|
1118-1136
|
|
New Robots
Sudhir Rawal, India
|
|
1136-1154
|
|
The Rising Importance of Social Media in Urological Education
Jeremy Yuen-Chun Teoh, Hong Kong
|
|
1154-1212
|
|
Improving Education on Endourology
Teng Aik Ong, Malaysia
|
|
1212-1230
|
|
Developing Robotic Surgery in the Middle East
|
|
1230-1242
|
|
Q&A
|
|
1242-1245
|
|
Take-Home Messages
Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe the impacts of media in our management of patients
- Recognize the importance of educating young doctors on the state-of-the-art techniques, and
- Assess the future direction of urology
|
|
|
1115-1245
|
|
HT-04: Hot Topics 04 - Advances in Prostate Cancer
Co-Chairs: Shusuke Akamatsu, Japan / Masatoshi Eto, Japan
|
|
1115-1120
|
|
Introduction
Masatoshi Eto, Japan
|
|
1120-1140
|
|
New Advances in Transperineal Prostatic Biopsy
|
|
1140-1200
|
|
Who Should have Genomic Tests to Be Treated with PARP Inhibitors and When?
Todd Morgan, United States
|
|
1200-1220
|
|
Novel Biomarkers in Prostate Cancer (liquid biopsy, CTC, cell-free DNA etc)
Shusuke Akamatsu, Japan
|
|
1220-1240
|
|
Locoregional Relapse of Prostate Cancer for Local Therapy
|
|
1240-1245
|
|
Q&A and Discussion
Shusuke Akamatsu, Japan
Masatoshi Eto, Japan
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize the benefit of transperineal prostatic biopsy over conventional transrectal biopsy
- Judge which patients with advanced prostate cancer would benefit from genomic testing and when to test them
- Summarize the specific features of different liquid biopsies and describe the clinical use of each liquid biopsy
- Describe different methods of local therapy for locoregional relapse of prostate cancer, including their risks and benefits
|
|
|
1115-1245
|
|
IC-02: Instructional Course 02 - Orthotopic Reconstruction: How to Improve Outcomes
Chair: Richard Hautmann
|
|
1115-1140
|
|
Physiologic Basis and Surgical Tips for a Neobladder with Improved Functional Outcome
Richard Hautmann
|
|
1140-1205
|
|
Tips and Tricks of Nerve Sparing Cystectomy and i-pouch or Ileal Neobladder
Arnulf Stenzl, Germany
|
|
1205-1230
|
|
How to Improve Outcomes of Open Orthotopic Reconstruction?
Sia Daneshmand, United States
|
|
1230-1245
|
|
Discussion
Sia Daneshmand, United States
Richard Hautmann
Arnulf Stenzl, Germany
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand that most surgeons use too small reservoirs. A minimum ileal segment of 50 cm (better 60) is required.
- Explain that resevoir shape plays a major role. A U-shaped reservoir has a pressure twoice as high as a W-shaped reservoir.
- Recall that perfect detutularization is a must. Any tubular segments must be avoided.
- Apply cross folding of the reservoir which is a must!
- Conclude that a nerve sparing RC will result in superior continence.
|
|
|
1115-1245
|
|
IC-14: Instructional Course 14 - Nuestros Trucos Técnicos en Cirugía Uretral (Course in Spanish) [Our Technical Tricks in Urethral Surgery]
Chair: Reynaldo Gómez, Chile
Faculty: Leonardo Capiel, Argentina / Jessica DeLong, United States / Javier Ponce de León, Spain
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- See surgical techniques with pearls from experts in the field with an interactive approach
- Understand oral mucosal and other graft harvest and fixation options
- Appreciate how to troubleshoot various reconstructive surgeries and manage (and avoid) common complications
- Learn how to utilize various surgical tools to improve outcomes
|
|
1115-1245
|
|
JS-03: Joint SIU-International Continence Society (ICS) Session
Co-Chairs: David Castro-Díaz, Spain / John Heesakkers, The Netherlands
Faculty: Rizwan Hamid, United Kingdom / Sherif Mourad, Egypt
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the concept and physiopathology of “complex SUI in women”
- Identify and select the proper management of mixed urinary incontinence
- Diagnose and indicate the adequate management of intrinsic sphincter dysfunction, recurrent SUI, neurogenic SUI as well as concurrent vesicovaginal fistula or urethral diverticula in women with stress urinary incontinence
|
|
1115-1245
|
|
JS-04: Joint SIU-Society of Urologic Robotic Surgeons (SURS) Session
Chair: Ashutosh Tewari, United States
|
|
1245-1415
|
|
Lunch Break
|
|
1415-1545
|
|
CO-01: Controversies in Urology 01 - High-Risk Prostate Cancer, Adjuvant & Salvage Therapies
Co-Chairs: Uğur Selek, Turkey / Derya Tilki, Germany
Faculty: Todd Morgan, United States
|
|
1415-1545
|
|
CO-02: Controversies in Urology 02 - Sexual Dysfunction and Infertility: What Works and What Does Not?
Co-Chair: Ajay Nehra, United States
|
|
1415-1545
|
|
IC-15: Instructional Course 15 - Virtual Care, TeleUrology, Digital Health - Full Complement of Patient-Centred Urologic Care: The Time is Now!
Chair: Emmanuel Abara, Canada
|
|
1415-1545
|
|
MV-03: Master Videos 03 - Complex Upper-tract Reconstructive Surgery
Co-Chairs: Petr Macek, France / Kurt McCammon, United States
|
|
1415-1545
|
|
SIU Resident Development Programme
|
|
1545-1615
|
|
Break
|
|
1615-1745
|
|
IC-16: Instructional Course 16 - Testosterone, the Prostate and Cardiovascular Disease: Addressing Safety and Efficacy in Testosterone Replacement Therapy
Chair: Brian Birch, United Kingdom
|
|
1615-1745
|
|
IC-17: Instructional Course 17 - Risk Reducing Surgery in Urology: For Whom, When and How?
Chair: Yiğit Akın, Turkey
Moderators: Jean de la Rosette, Turkey / Pilar Laguna, Turkey
Faculty: Peter Carroll, United States / Badrinath Konety, United States / W. Marston Linehan, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recall the description of prophylactic surgery in the urological field
- Determine a diagnostic assessment including laboratory and imaging methods application areas
- Outline techniques and advantages (quality of life and anxiety issues)
- Explain Surveillance and Future directions in Prophylactic Urological Surgery
- Describe the Current status of Prophylactic Urological Surgery
|
|
1615-1745
|
|
IS-02: Interactive Session 02 -Renal Transplantation Frontiers
Co-Chairs: Sunil Shroff, India / Puneet Sindhwani, United States
|
|
1615-1745
|
|
JS-05: Joint SIU-Society of Genitourinary Reconstructive Surgeons (GURS) Session
Co-Chairs: Andre Cavalcanti, Brazil / Reynaldo Gómez, Chile / Kurt McCammon, United States
Faculty: Marta Bizic, Serbia
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify the complexities of the management of sex development and gender-affirming surgery and the current available tools for their treatment
- Recognize the pros and cons of reconstruction versus urinary diversion for the management of radiation induced urethral stenosis
- Analyze the current evidence to support endoscopic urethrotomy as a cost effective first line approach for anterior urethral strictures
- Judge the value of live surgery courses and their impact on surgical education, considering their cost and possible risks for the patients
|
|
1615-1745
|
|
MV-04: Master Videos 04 - Laparoscopy Sans the Robot
Co-Chairs: Chiruvella Mallikarjuna, India / Nasser Simforoosh, Iran
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Learn the finer nuances in some common laparoscopic urological surgeries
- Identify some technical modifications in the techniques of lap pyeloplasty to improve surgical outcomes
- Recall that there are many different ways to excise a renal tumor and do the renography laparoscopically, few of those will be demonstrated
- Recognize that continence is of prime importance in RP and many maneuvers are there to improve it and are demonstrated
- Conclude that cystectomy done laparoscopically has to be done in a stepwise fashion and all the steps are learnt by this presentation
- Understand that early vascular control during lap adrenalectomy is needed to control blood pressure during surgery of functional adrenal tumors, which will be explained; live interaction will be possible during the presentation
|
Sunday, November 14
Please click on the session titles to view the session details when available.
|
0730-0900
|
|
IC-18: Instructional Course 18 - Advanced Ureteroscopy
Chair: Michael Grasso, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Reinforce ureteroscopic technique and expand on new innovative treatments
- Comprehensive review of ureteroscopic lithotripsy
- Present current state of the art therapies for upper urinary tract urothelial carcinoma
- Present detailed management strategies for upper urinary tract obstruction
- Reinforce preventative measures and treatment strategies for complications associated with RIRS
|
|
0730-0900
|
|
IC-19: Instructional Course 19 - Técnicas Quirúrgicas para HPB: Paso a Paso (2nd Course in Spanish) [Surgical Techniques for BPH: Step by Step]
Chair: Alejandro Rodriguez, United States
|
|
|
|
0800-0900
|
|
MC-05: Master Class 05 - Biomarkers in Cancer
Co-Chairs: Sia Daneshmand, United States / Seth Lerner, United States
|
|
0800-0900
|
|
MC-06: Master Class 06 - Undescended Testis (UDT)
Co-Chair: Tarkan Soygur, Turkey
|
|
0800-0900
|
|
MC-07: Master Class 07 - Complex Reconstruction (Lower-tract)
Co-Chairs: Melanie Aube-Peterkin, Canada / Jaspreet S. Sandhu, United States
Faculty: Marta Bizic, Serbia / Shrawan Kumar Singh, India
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe tissue engineering options for complex lower tract reconstruction
- Analyze and discuss options for surgical care and reconstruction of complex lower urinary tract disease
- Recognize the importance of patient experience when addressing complex lower tract reconstruction
|
|
0900-1045
|
|
PL-03: Plenary 03
|
|
0935-0950
|
|
European Association of Urology (EAU) Lecture
Arnulf Stenzl, Germany
Learning Objectives:
At the end of Dr. Stenzl's lecture, attendees will be able to:
- Differentiate between various forms of treatment, i.e. conservative, interventional, surgical in prostate cancer patients with comorbidities
- Differentiate between regionally advanced, oligometastatic and metastatic (de novo and recurrent) disease and the impact of patients' comorbidities
- Show possible pathomechanisms of diabetes mellitus which could interfere with the prognosis of prostate cancer
|
|
0950-1005
|
|
American Urological Association (AUA) Lecture: Renal Mass Guideline Update
Sam Chang, United States
Learning Objectives:
At the end of Dr. Chang's lecture, attendees will be able to:
- Recognize the importance of risk-stratified diagnosis, care, and surveillance follow-up
- Provide multi-disciplinary options for renal cancer
- Update the criteria and role of active surveillance
- Promote the need for continued clinical trials
|
|
1005-1020
|
|
State-of-the-Art Lecture: Testicular Cancer (New Markers, Changing Face of Testicular Cancer)
Joel Sheinfeld, United States
|
|
|
1045-1115
|
|
Break
|
|
1115-1245
|
|
CO-03: Controversies in Urology 03 - Functional Outcomes of Stone Surgery
Co-Chairs: Mahesh R. Desai, India / Anthony C.F. Ng, Hong Kong
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Discuss whether computed tomography (CT) is good enough for the assessment of renal function in stone and non-stone conditions
- Explain the role of additional functional scan in clinical situations
- Evaluate whether combined is better than single modality, with a focus on efficacy, efficiency and cost consideration
- Understand the pros and cons of different modalities of stone treatment in ectopic kidney stones
|
|
1115-1245
|
|
HT-05: Hot Topics 05 - Emerging Infections and Their Impact on Urology
Speakers: Mete Çek, Turkey / Ramaiah Keshavamurthy, India
|
|
1115-1245
|
|
JS-06: Joint SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU)
Co-Chairs: Michael Cookson, United States / Morgan Roupret, France
Faculty: Maria Carmen Mir, United States / Sanjay G. Patel, United States
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize the impact of current international guidelines on the management of patients with invasive bladder cancer
- Recall the clinical, pathologic and molecular characteristics that impact on selection of patients for neoadjuvant chemotherapy
- Discuss the latest advances in robotic and minimally invasive surgical techniques in the management of invasive bladder cancer
- Evaluate recent clinical trial results and new combination therapies for the treatment of urothelial bladder cancer including BCG unresponsive and upper tract tumors
|
|
1245-1415
|
|
Lunch Break
|
|
1415-1545
|
|
MV-05: Master Videos 05 - Robotics: State of the Art
Co-Chairs: Monish Aron, United States / Shigeo Horie, Japan
|
|
1415-1545
|
|
MV-06: Master Videos 06 - RIRS and PCNL
Co-Chairs: Daniel Pérez-Fentes, Spain / Ravindra Sabnis, India
|
|
1415-1420
|
|
Introduction
Daniel Pérez-Fentes, Spain
Ravindra Sabnis, India
|
|
1420-1435
|
|
RIRS in a Conventional Case, Step by Step
Thomas Hsueh, Taiwan
|
|
1435-1440
|
|
Discussion
Thomas Hsueh, Taiwan
|
|
1440-1455
|
|
RIRS in Challenging Situations: How to Make the Most of New Technologies
Thomas Tailly, Belgium
|
|
1455-1500
|
|
Discussion
Thomas Tailly, Belgium
|
|
1500-1515
|
|
Miniaturized PCNL and Standard PERC: Basic Steps and Clinical Application
Vitor Cavadas, Portugal
|
|
1515-1520
|
|
Discussion
Vitor Cavadas, Portugal
|
|
1520-1535
|
|
ECIRS and Mini-ECIRS: Why and How
Daniel Pérez-Fentes, Spain
|
|
1535-1540
|
|
Discussion
Daniel Pérez-Fentes, Spain
|
|
1540-1545
|
|
Take-home Message
Daniel Pérez-Fentes, Spain
Ravindra Sabnis, India
|
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify the critical steps in RIRS, PCNL and ECIRS.
- Evaluate the pros and cons of the different endourological approaches for stone treatment
- Manage the different treatment options in a comprehensive manner
|
Reynaldo Gómez• Joint SIU-International Society of Reconstructive Urology (ISORU) Session
Co-Chair• Joint SIU-Society of Genitourinary Reconstructive Surgeons (GURS) Session
Co-Chair• Instructional Course 14 - Nuestros Trucos Técnicos en Cirugía Uretral (Course in Spanish) [Our Technical Tricks in Urethral Surgery]
Chair • Biography • Disclosure information
Laurence Klotz• International Consultation on Urological Diseases (ICUD) and World Urologic Oncology Federation (WUOF) Consultation: Molecular Biomarkers in Urology
Chair• World Urological Oncology Federation (WUOF) Symposium
Co-Chair• SIU Tips and Tricks Session
Chair • Biography • Disclosure information
Sherif Mourad• Master Videos 01 - Genitourinary Fistulae
Co-Chair• Instructional Course 08 - Case Based Discussions in Neuro-urology
Faculty• Joint SIU-International Continence Society (ICS) Session
Faculty • Biography • Disclosure information
Rafael Sanchez-Salas• Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
Co-Chair• Semi-Live Surgery
Co-Chair• Instructional Course 07 - Focal Therapy for Locoregional or Oligometastatic Recurrence of Prostate Cancer
Chair • Biography • Disclosure information
